
Company Number
03218090
Next Accounts
Sep 2025
Shareholders
fresenius medical care beteiligungsgesellschaft gmbh
Group Structure
View All
Industry
Other human health activities
Registered Address
nunn brook road, huthwaite, sutton in ashfield, nottinghamshire, NG17 2HU
Website
fmcna.comPomanda estimates the enterprise value of FRESENIUS MEDICAL CARE (HOLDINGS) LIMITED at £124.6m based on a Turnover of £148.5m and 0.84x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of FRESENIUS MEDICAL CARE (HOLDINGS) LIMITED at £97.9m based on an EBITDA of £15.1m and a 6.47x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of FRESENIUS MEDICAL CARE (HOLDINGS) LIMITED at £153m based on Net Assets of £65.1m and 2.35x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Fresenius Medical Care (holdings) Limited is a live company located in sutton in ashfield, NG17 2HU with a Companies House number of 03218090. It operates in the other human health activities sector, SIC Code 86900. Founded in June 1996, it's largest shareholder is fresenius medical care beteiligungsgesellschaft gmbh with a 100% stake. Fresenius Medical Care (holdings) Limited is a mature, mega sized company, Pomanda has estimated its turnover at £148.5m with low growth in recent years.
Pomanda's financial health check has awarded Fresenius Medical Care (Holdings) Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 7 areas for improvement. Company Health Check FAQs
4 Strong
1 Regular
7 Weak
Size
annual sales of £148.5m, make it larger than the average company (£798.1k)
£148.5m - Fresenius Medical Care (holdings) Limited
£798.1k - Industry AVG
Growth
3 year (CAGR) sales growth of 2%, show it is growing at a slower rate (6.5%)
2% - Fresenius Medical Care (holdings) Limited
6.5% - Industry AVG
Production
with a gross margin of 18%, this company has a higher cost of product (36.5%)
18% - Fresenius Medical Care (holdings) Limited
36.5% - Industry AVG
Profitability
an operating margin of 7% make it more profitable than the average company (5.6%)
7% - Fresenius Medical Care (holdings) Limited
5.6% - Industry AVG
Employees
with 799 employees, this is above the industry average (19)
799 - Fresenius Medical Care (holdings) Limited
19 - Industry AVG
Pay Structure
on an average salary of £46.6k, the company has a higher pay structure (£27k)
£46.6k - Fresenius Medical Care (holdings) Limited
£27k - Industry AVG
Efficiency
resulting in sales per employee of £185.8k, this is more efficient (£51.5k)
£185.8k - Fresenius Medical Care (holdings) Limited
£51.5k - Industry AVG
Debtor Days
it gets paid by customers after 136 days, this is later than average (22 days)
136 days - Fresenius Medical Care (holdings) Limited
22 days - Industry AVG
Creditor Days
its suppliers are paid after 18 days, this is close to average (17 days)
18 days - Fresenius Medical Care (holdings) Limited
17 days - Industry AVG
Stock Days
it holds stock equivalent to 60 days, this is more than average (16 days)
60 days - Fresenius Medical Care (holdings) Limited
16 days - Industry AVG
Cash Balance
has cash to cover current liabilities for 0 weeks, this is less cash available to meet short term requirements (101 weeks)
0 weeks - Fresenius Medical Care (holdings) Limited
101 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 55.8%, this is a higher level of debt than the average (27.9%)
55.8% - Fresenius Medical Care (holdings) Limited
27.9% - Industry AVG
Fresenius Medical Care (Holdings) Limited's latest turnover from December 2023 is £148.5 million and the company has net assets of £65.1 million. According to their latest financial statements, Fresenius Medical Care (Holdings) Limited has 799 employees and maintains cash reserves of £196 thousand as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 148,463,000 | 132,835,000 | 131,109,000 | 138,492,000 | 132,433,000 | 125,676,000 | 126,034,000 | 122,805,000 | 119,461,000 | 115,420,000 | 112,464,000 | 110,117,000 | 108,659,000 | 111,839,000 | 108,437,000 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 121,784,000 | 105,700,000 | 103,543,000 | 110,282,000 | 111,927,000 | 99,828,000 | 99,072,000 | 95,184,000 | 89,699,000 | 90,145,000 | 87,995,000 | 83,380,000 | 81,519,000 | 84,248,000 | 88,867,000 |
Gross Profit | 26,679,000 | 27,135,000 | 27,566,000 | 28,210,000 | 20,506,000 | 25,848,000 | 26,962,000 | 27,621,000 | 29,762,000 | 25,275,000 | 24,469,000 | 26,737,000 | 27,140,000 | 27,591,000 | 19,570,000 |
Admin Expenses | 16,253,000 | 18,008,000 | 19,356,000 | 22,719,000 | 20,105,000 | 19,328,000 | 21,770,000 | 21,523,000 | 12,990,000 | 15,997,000 | 18,620,000 | 18,439,000 | 16,284,000 | 17,808,000 | 15,410,000 |
Operating Profit | 10,426,000 | 9,127,000 | 8,210,000 | 5,491,000 | 401,000 | 6,520,000 | 5,192,000 | 6,098,000 | 16,772,000 | 9,278,000 | 5,849,000 | 8,298,000 | 10,856,000 | 9,783,000 | 4,160,000 |
Interest Payable | 174,000 | 21,000 | 231,000 | 613,000 | 525,000 | 599,000 | 619,000 | 710,000 | 859,000 | 464,000 | 526,000 | 1,331,000 | 1,597,000 | 1,353,000 | 902,000 |
Interest Receivable | 1,943,000 | 716,000 | 37,000 | 406,000 | 356,000 | 331,000 | 227,000 | 49,000 | 82,000 | 35,000 | 43,000 | 357,000 | 427,000 | 428,000 | 55,000 |
Pre-Tax Profit | 12,252,000 | 9,822,000 | 8,016,000 | 5,284,000 | 232,000 | -1,318,000 | 4,754,000 | 5,382,000 | 16,171,000 | 8,559,000 | 5,336,000 | 7,259,000 | 11,900,000 | 8,784,000 | 3,105,000 |
Tax | -2,138,000 | -1,095,000 | -1,162,000 | -1,722,000 | -113,000 | -1,880,000 | -1,152,000 | -2,262,000 | -3,983,000 | -1,827,000 | -1,404,000 | -2,150,000 | -3,286,000 | -2,369,000 | -1,530,000 |
Profit After Tax | 10,114,000 | 8,727,000 | 6,854,000 | 3,562,000 | 119,000 | -3,198,000 | 3,602,000 | 3,120,000 | 12,188,000 | 6,732,000 | 3,932,000 | 5,109,000 | 8,614,000 | 6,415,000 | 1,575,000 |
Dividends Paid | 2,880,000 | 2,262,000 | 2,220,000 | 4,403,000 | 5,700,000 | 4,892,000 | 1,311,000 | 2,674,000 | 2,138,000 | 508,000 | 1,170,000 | ||||
Retained Profit | 7,234,000 | 6,465,000 | 4,634,000 | -841,000 | -5,581,000 | -8,090,000 | 3,602,000 | 3,120,000 | 12,188,000 | 5,421,000 | 3,932,000 | 2,435,000 | 6,476,000 | 5,907,000 | 405,000 |
Employee Costs | 37,273,000 | 32,693,000 | 33,524,000 | 36,802,000 | 36,254,000 | 35,560,000 | 34,442,000 | 34,641,000 | 34,523,000 | 31,963,000 | 32,708,000 | 31,754,000 | 31,577,000 | 29,768,000 | 26,998,000 |
Number Of Employees | 799 | 891 | 1,030 | 1,111 | 864 | 816 | 851 | 863 | 836 | 808 | 801 | 764 | 856 | 799 | 743 |
EBITDA* | 15,143,000 | 15,413,000 | 13,426,000 | 12,668,000 | 8,577,000 | 14,000,000 | 11,808,000 | 13,823,000 | 24,517,000 | 15,080,000 | 11,965,000 | 14,173,000 | 17,221,000 | 15,527,000 | 9,212,000 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 28,680,000 | 23,986,000 | 26,598,000 | 29,823,000 | 36,933,000 | 40,899,000 | 36,464,000 | 44,522,000 | 48,570,000 | 48,918,000 | 47,972,000 | 46,079,000 | 46,762,000 | 51,827,000 | 45,436,000 |
Intangible Assets | 354,000 | 8,000 | 1,565,000 | 3,120,000 | 4,696,000 | 6,198,000 | 7,738,000 | 9,318,000 | 10,912,000 | 12,526,000 | 14,000 | 21,000 | 138,000 | 368,000 | 596,000 |
Investments & Other | 324,000 | 14,000 | |||||||||||||
Debtors (Due After 1 year) | 48,000 | 64,000 | 20,000 | 126,000 | 170,000 | 171,000 | 175,000 | 175,000 | 222,000 | 243,000 | 1,776,000 | 1,155,000 | 1,458,000 | 421,000 | |
Total Fixed Assets | 29,082,000 | 24,058,000 | 28,507,000 | 33,069,000 | 41,813,000 | 47,268,000 | 44,377,000 | 54,015,000 | 59,704,000 | 61,687,000 | 49,762,000 | 47,255,000 | 48,358,000 | 52,195,000 | 46,453,000 |
Stock & work in progress | 20,234,000 | 14,495,000 | 11,657,000 | 12,909,000 | 11,218,000 | 8,449,000 | 8,230,000 | 8,084,000 | 8,574,000 | 7,238,000 | 4,499,000 | 3,794,000 | 2,809,000 | 3,374,000 | 3,170,000 |
Trade Debtors | 55,451,000 | 33,149,000 | 21,126,000 | 20,067,000 | 34,164,000 | 27,817,000 | 33,764,000 | 31,626,000 | 27,449,000 | 25,828,000 | 23,770,000 | 17,484,000 | 17,170,000 | 18,272,000 | 20,141,000 |
Group Debtors | 33,349,000 | 43,191,000 | 39,823,000 | 49,788,000 | 17,668,000 | 24,494,000 | 39,301,000 | 27,958,000 | 22,369,000 | 13,611,000 | 6,355,000 | 5,171,000 | 5,742,000 | 8,086,000 | 2,459,000 |
Misc Debtors | 8,984,000 | 8,432,000 | 6,644,000 | 9,082,000 | 10,324,000 | 9,016,000 | 8,677,000 | 7,080,000 | 5,867,000 | 7,819,000 | 4,597,000 | 5,441,000 | 6,455,000 | 5,014,000 | 5,664,000 |
Cash | 196,000 | 59,000 | 48,000 | 49,000 | 253,000 | 480,000 | 462,000 | 618,000 | 612,000 | 3,879,000 | 1,698,000 | 1,874,000 | 1,307,000 | 183,000 | 851,000 |
misc current assets | |||||||||||||||
total current assets | 118,214,000 | 99,326,000 | 79,298,000 | 91,895,000 | 73,627,000 | 70,256,000 | 90,434,000 | 75,366,000 | 64,871,000 | 58,375,000 | 40,919,000 | 33,764,000 | 33,483,000 | 34,929,000 | 32,285,000 |
total assets | 147,296,000 | 123,384,000 | 107,805,000 | 124,964,000 | 115,440,000 | 117,524,000 | 134,811,000 | 129,381,000 | 124,575,000 | 120,062,000 | 90,681,000 | 81,019,000 | 81,841,000 | 87,124,000 | 78,738,000 |
Bank overdraft | |||||||||||||||
Bank loan | |||||||||||||||
Trade Creditors | 6,292,000 | 3,848,000 | 5,783,000 | 3,624,000 | 5,177,000 | 3,508,000 | 6,932,000 | 6,065,000 | 4,348,000 | 6,354,000 | 4,527,000 | 3,518,000 | 4,440,000 | 5,377,000 | 8,534,000 |
Group/Directors Accounts | 32,883,000 | 20,206,000 | 8,577,000 | 29,449,000 | 21,923,000 | 26,534,000 | 36,310,000 | 38,237,000 | 20,364,000 | 29,385,000 | 13,694,000 | 12,106,000 | 8,303,000 | 8,622,000 | 12,595,000 |
other short term finances | 1,142,000 | ||||||||||||||
hp & lease commitments | 168,000 | 605,000 | 997,000 | 1,212,000 | 1,346,000 | 1,260,000 | 1,125,000 | ||||||||
other current liabilities | 28,577,000 | 25,169,000 | 24,911,000 | 26,992,000 | 25,135,000 | 21,109,000 | 18,838,000 | 17,279,000 | 18,411,000 | 19,097,000 | 13,578,000 | 10,843,000 | 10,642,000 | 10,007,000 | 10,089,000 |
total current liabilities | 67,752,000 | 49,223,000 | 39,271,000 | 60,065,000 | 52,235,000 | 51,151,000 | 62,080,000 | 61,581,000 | 43,291,000 | 56,583,000 | 32,796,000 | 27,679,000 | 24,731,000 | 25,266,000 | 32,343,000 |
loans | 17,995,000 | 13,650,000 | 16,023,000 | 16,151,000 | 21,261,000 | 32,860,000 | 23,993,000 | ||||||||
hp & lease commitments | 168,000 | 772,000 | 1,769,000 | 2,890,000 | 2,895,000 | 2,114,000 | |||||||||
Accruals and Deferred Income | 7,391,000 | 7,406,000 | 7,160,000 | 6,171,000 | 5,853,000 | 5,506,000 | 5,145,000 | 3,184,000 | 2,871,000 | 2,290,000 | 161,000 | ||||
other liabilities | |||||||||||||||
provisions | 6,262,000 | 7,784,000 | 8,752,000 | 10,507,000 | 8,384,000 | 5,449,000 | 3,718,000 | 3,540,000 | 3,844,000 | 2,892,000 | 3,683,000 | 1,869,000 | 1,744,000 | 1,371,000 | 1,541,000 |
total long term liabilities | 14,418,000 | 16,315,000 | 15,912,000 | 17,891,000 | 14,237,000 | 12,230,000 | 12,584,000 | 11,880,000 | 27,554,000 | 22,445,000 | 21,862,000 | 21,565,000 | 28,531,000 | 38,931,000 | 29,339,000 |
total liabilities | 82,170,000 | 65,538,000 | 55,183,000 | 77,956,000 | 66,472,000 | 63,381,000 | 74,664,000 | 73,461,000 | 70,845,000 | 79,028,000 | 54,658,000 | 49,244,000 | 53,262,000 | 64,197,000 | 61,682,000 |
net assets | 65,126,000 | 57,846,000 | 52,622,000 | 47,008,000 | 48,968,000 | 54,143,000 | 60,147,000 | 55,920,000 | 53,730,000 | 41,034,000 | 36,023,000 | 31,775,000 | 28,579,000 | 22,927,000 | 17,056,000 |
total shareholders funds | 65,126,000 | 57,846,000 | 52,622,000 | 47,008,000 | 48,968,000 | 54,143,000 | 60,147,000 | 55,920,000 | 53,730,000 | 41,034,000 | 36,023,000 | 31,775,000 | 28,579,000 | 22,927,000 | 17,056,000 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 10,426,000 | 9,127,000 | 8,210,000 | 5,491,000 | 401,000 | 6,520,000 | 5,192,000 | 6,098,000 | 16,772,000 | 9,278,000 | 5,849,000 | 8,298,000 | 10,856,000 | 9,783,000 | 4,160,000 |
Depreciation | 4,702,000 | 4,729,000 | 5,216,000 | 5,601,000 | 6,608,000 | 5,914,000 | 5,036,000 | 6,108,000 | 6,077,000 | 5,799,000 | 6,109,000 | 5,758,000 | 6,135,000 | 5,532,000 | 4,822,000 |
Amortisation | 15,000 | 1,557,000 | 1,576,000 | 1,568,000 | 1,566,000 | 1,580,000 | 1,617,000 | 1,668,000 | 3,000 | 7,000 | 117,000 | 230,000 | 212,000 | 230,000 | |
Tax | -2,138,000 | -1,095,000 | -1,162,000 | -1,722,000 | -113,000 | -1,880,000 | -1,152,000 | -2,262,000 | -3,983,000 | -1,827,000 | -1,404,000 | -2,150,000 | -3,286,000 | -2,369,000 | -1,530,000 |
Stock | 5,739,000 | 2,838,000 | -1,252,000 | 1,691,000 | 2,769,000 | 219,000 | 146,000 | -490,000 | 1,336,000 | 2,739,000 | 705,000 | 985,000 | -565,000 | 204,000 | 3,170,000 |
Debtors | 12,996,000 | 17,223,000 | -11,450,000 | 16,737,000 | 828,000 | -20,419,000 | 15,078,000 | 10,932,000 | 8,406,000 | 11,003,000 | 7,247,000 | -1,574,000 | -547,000 | 2,687,000 | 28,685,000 |
Creditors | 2,444,000 | -1,935,000 | 2,159,000 | -1,553,000 | 1,669,000 | -3,424,000 | 867,000 | 1,717,000 | -2,006,000 | 1,827,000 | 1,009,000 | -922,000 | -937,000 | -3,157,000 | 8,534,000 |
Accruals and Deferred Income | 3,393,000 | 504,000 | -1,092,000 | 2,175,000 | 4,373,000 | 2,632,000 | 3,520,000 | -819,000 | -105,000 | 7,809,000 | 2,735,000 | 40,000 | 796,000 | -82,000 | 10,089,000 |
Deferred Taxes & Provisions | -1,522,000 | -968,000 | -1,755,000 | 2,123,000 | 2,935,000 | 1,731,000 | 178,000 | -304,000 | 952,000 | -791,000 | 1,814,000 | 125,000 | 373,000 | -170,000 | 1,541,000 |
Cash flow from operations | -1,415,000 | -8,142,000 | 24,278,000 | -4,737,000 | 13,844,000 | 33,259,000 | -3,000 | 1,713,000 | 9,633,000 | 8,356,000 | 8,167,000 | 11,855,000 | 15,279,000 | 6,858,000 | -4,009,000 |
Investing Activities | |||||||||||||||
capital expenditure | 7,145,000 | 9,256,000 | 3,775,000 | 379,000 | 215,000 | ||||||||||
Change in Investments | -324,000 | 324,000 | -14,000 | 14,000 | |||||||||||
cash flow from investments | 324,000 | -324,000 | 14,000 | -14,000 | 7,145,000 | 9,256,000 | 3,775,000 | 379,000 | 215,000 | ||||||
Financing Activities | |||||||||||||||
Bank loans | |||||||||||||||
Group/Directors Accounts | 12,677,000 | 11,629,000 | -20,872,000 | 7,526,000 | -4,611,000 | -9,776,000 | -1,927,000 | 17,873,000 | -9,021,000 | 15,691,000 | 1,588,000 | 3,803,000 | -319,000 | -3,973,000 | 12,595,000 |
Other Short Term Loans | -1,142,000 | 1,142,000 | |||||||||||||
Long term loans | -17,995,000 | 4,345,000 | -2,373,000 | -128,000 | -5,110,000 | -11,599,000 | 8,867,000 | 23,993,000 | |||||||
Hire Purchase and Lease Commitments | -168,000 | -605,000 | -996,000 | -1,212,000 | -1,255,000 | 81,000 | 916,000 | 3,239,000 | |||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | 1,769,000 | 695,000 | -194,000 | -207,000 | -169,000 | -268,000 | -392,000 | -661,000 | -777,000 | -429,000 | -483,000 | -974,000 | -1,170,000 | -925,000 | -847,000 |
cash flow from financing | 14,492,000 | 11,083,000 | -20,086,000 | 6,200,000 | -4,374,000 | -7,958,000 | -1,694,000 | -1,881,000 | -6,692,000 | 12,625,000 | 81,000 | -2,775,000 | -13,831,000 | 4,849,000 | 55,631,000 |
cash and cash equivalents | |||||||||||||||
cash | 137,000 | 11,000 | -1,000 | -204,000 | -227,000 | 18,000 | -156,000 | 6,000 | -3,267,000 | 2,181,000 | -176,000 | 567,000 | 1,124,000 | -668,000 | 851,000 |
overdraft | |||||||||||||||
change in cash | 137,000 | 11,000 | -1,000 | -204,000 | -227,000 | 18,000 | -156,000 | 6,000 | -3,267,000 | 2,181,000 | -176,000 | 567,000 | 1,124,000 | -668,000 | 851,000 |
Perform a competitor analysis for fresenius medical care (holdings) limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other mega companies, companies in NG17 area or any other competitors across 12 key performance metrics.
FRESENIUS MEDICAL CARE (HOLDINGS) LIMITED group structure
Fresenius Medical Care (Holdings) Limited has 5 subsidiary companies.
Ultimate parent company
FRESENIUS MANAGEMENT SE
#0131647
FRESENIUS MEDICAL CARE BETEILIGUNGSGESEL
#0119592
2 parents
FRESENIUS MEDICAL CARE (HOLDINGS) LIMITED
03218090
5 subsidiaries
Fresenius Medical Care (Holdings) Limited currently has 3 directors. The longest serving directors include Ms Laura Bell (Nov 2017) and Mr Christopher Slater (Jul 2023).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Ms Laura Bell | 43 years | Nov 2017 | - | Director | |
Mr Christopher Slater | England | 43 years | Jul 2023 | - | Director |
Ms Anita Singh Williams | 57 years | Jul 2023 | - | Director |
P&L
December 2023turnover
148.5m
+12%
operating profit
10.4m
+14%
gross margin
18%
-12.03%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
65.1m
+0.13%
total assets
147.3m
+0.19%
cash
196k
+2.32%
net assets
Total assets minus all liabilities
company number
03218090
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
June 1996
age
29
incorporated
UK
ultimate parent company
accounts
Group
last accounts submitted
December 2023
previous names
inhoco 520 limited (July 1996)
accountant
-
auditor
COOPER PARRY GROUP LIMITED
address
nunn brook road, huthwaite, sutton in ashfield, nottinghamshire, NG17 2HU
Bank
-
Legal Advisor
-
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 1 charges/mortgages relating to fresenius medical care (holdings) limited. Currently there are 1 open charges and 0 have been satisfied in the past.
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for FRESENIUS MEDICAL CARE (HOLDINGS) LIMITED. This can take several minutes, an email will notify you when this has completed.
date | description | view/download |
---|